Cargando…
MCL-1 is a prognostic indicator and drug target in breast cancer
Analysis of publicly available genomic and gene expression data demonstrates that MCL1 expression is frequently elevated in breast cancer. Distinct from other pro-survival Bcl-2 family members, the short half-life of MCL-1 protein led us to investigate MCL-1 protein expression in a breast cancer tis...
Autores principales: | Campbell, Kirsteen J., Dhayade, Sandeep, Ferrari, Nicola, Sims, Andrew H., Johnson, Emma, Mason, Susan M., Dickson, Ashley, Ryan, Kevin M., Kalna, Gabriela, Edwards, Joanne, Tait, Stephen W. G., Blyth, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833338/ https://www.ncbi.nlm.nih.gov/pubmed/29339815 http://dx.doi.org/10.1038/s41419-017-0035-2 |
Ejemplares similares
-
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function
por: Campbell, Kirsteen J., et al.
Publicado: (2021) -
MCL-1 is a clinically targetable vulnerability in breast cancer
por: Winder, Matthew L, et al.
Publicado: (2022) -
Impact of Formate Supplementation on Body Weight and Plasma Amino Acids
por: Dhayade, Sandeep, et al.
Publicado: (2020) -
The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma
por: Birch, Joanna, et al.
Publicado: (2016) -
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice
por: Anstee, Natasha S, et al.
Publicado: (2017)